Watchlist Price Alert

Sigilon Therapeutics Inc. (SGTX)

NASDAQ: SGTX · Real-Time Price · USD

22.47

-0.59 (-2.56%)

At close: Aug 10, 2023, 8:00 PM

Sigilon Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-43.56M	-77.31M	-54.61M	-43.92M	-22.77M
Depreciation & Amortization	1.26M	1.12M	854K	675K	374K
Stock-Based Compensation	5.9M	6.15M	3.13M	2.07M	821K
Other Working Capital	-15.92M	-9.41M	-12.91M	-13.17M	58.94M
Other Non-Cash Items	4.19M	5.06M	-7.62M	1.79M	19K
Deferred Income Tax	n/a	3K	-854K	207K	99K
Change in Working Capital	-19.27M	-13.42M	-2.55M	-10.89M	59.78M
Operating Cash Flow	-51.47M	-78.41M	-61.65M	-50.07M	38.33M
Capital Expenditures	-537K	-1.83M	-972K	-1.21M	-1.65M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-42.52M	-16.23M	n/a	n/a	n/a
Sales Maturities Of Investments	30.75M	n/a	n/a	n/a	n/a
Other Investing Acitivies	230K	n/a	n/a	n/a	n/a
Investing Cash Flow	-12.08M	-18.06M	-972K	-1.21M	-1.65M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	-622K	51.72M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.61M	1.55M	189.4M	63.24M	24.23M
Financial Cash Flow	-1.61M	1.55M	189.4M	63.24M	24.23M
Net Cash Flow	-65.16M	-94.91M	126.78M	11.96M	60.91M
Free Cash Flow	-52.01M	-80.24M	-62.62M	-51.28M	36.68M